Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Invested Capital (2016 - 2025)

Bio Key International's Invested Capital history spans 16 years, with the latest figure at $6.1 million for Q3 2025.

  • For Q3 2025, Invested Capital rose 2131.1% year-over-year to $6.1 million; the TTM value through Sep 2025 reached $6.1 million, up 2131.1%, while the annual FY2024 figure was $3.9 million, 267.14% up from the prior year.
  • Invested Capital for Q3 2025 was $6.1 million at Bio Key International, down from $7.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $19.6 million in Q1 2021 and bottomed at -$350241.0 in Q3 2023.
  • The 5-year median for Invested Capital is $7.3 million (2025), against an average of $8.1 million.
  • The largest annual shift saw Invested Capital tumbled 102.99% in 2023 before it skyrocketed 2131.1% in 2025.
  • A 5-year view of Invested Capital shows it stood at $15.6 million in 2021, then crashed by 49.42% to $7.9 million in 2022, then tumbled by 86.53% to $1.1 million in 2023, then skyrocketed by 267.14% to $3.9 million in 2024, then soared by 57.07% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Invested Capital are $6.1 million (Q3 2025), $7.3 million (Q2 2025), and $7.7 million (Q1 2025).